Co-Diagnostics Inc CODX shares are trading higher in Thursday's after-hours session after the company reported financial results and issued earnings guidance.
Co-Diagnostics reported full year 2021 revenue of $97.89 million, which is up $23.3 million year-over-year. The company reported earnings of $1.23 per share, which was down from earnings of $1.52 per share in 2020.
Co-Diagnostics expects first-quarter revenue to be between $21 and $22 million versus the $21.28 million estimate. The company expects first-quarter earnings to be in a range of 17 cents to 20 cents per share versus the 11 cent estimate.
Co-Diagnostics is a molecular diagnostics company focused on developing, licensing and commercializing molecular technologies.
See Also: Why Purple Innovation Stock Is Falling After Hours
CODX 52-Week Range: $5.00 - $14.67
The stock was up 5.99% in after hours at $6.90 at publication time.
Photo: kkolosov from Pixabay.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
